The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
Will give truer reflection on price movements of food products, impact of cereal procurement prices.
Climate change can impact the amount and quality of livestock produce,says a report released by inter-governmental panel.
The NPPA letter was issued to GSK on Wednesday.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
.jpg)
What started as a mere payment delay seems to have grown into a tussle between the government and leading private hospitals, empanelled under the Central Government Health Scheme.
Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.
The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.
State governments want the Centre to direct the 14th Finance Commission to compensate states for implementing pay scales, to be recommended by the pay panel.
CCI has accused realty player DLF of preparing one-sided agreement with home buyers
Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.
According to the final recommendations of an expert committee, the weight of primary (unprocessed) food items will go down by 0.5-1.0 percentage points in the new series compared to the current one
For 2014-15, the bill on this account is likely to be 12.8% more than in 2013-14.
Swiss drug maker Novartis might face tough action from the country's drug regulator for allegedly giving fake documents while seeking renewal of registration for Tiamulin Hydrogen Fumerate (80 per cent granules), sources said.
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
India will extend the visa-on-arrival facility to all countries except eight with effect from September. The countries not covered under this single-entry e-visa facility, meant for purposes other than paid employment and education with a one-month time limit, are Pakistan, Sudan, Afghanistan, Iran, Iraq, Nigeria, Sri Lanka and Somalia. The facility is currently available to 11 countries, including New Zealand, Singapore, Luxembourg, Japan and Finland.
Formal announcement of venture into new segment on Thursday; group's entry timely, given the demand, say experts
A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt.
Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.
Infrastructure investments in politically-expedient sectors such as water supply, sanitation and irrigation have seen an increase during the first year of the 12th Five-Year Plan (2012-13 to 2016-17), but the same did not get replicated in other critical sectors.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances